Heinecke JW - Search Results

1

Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis.

Gaut JP, Heinecke JW. Gaut JP, et al. Among authors: heinecke jw. Trends Cardiovasc Med. 2001 Apr-May;11(3-4):103-12. doi: 10.1016/s1050-1738(01)00101-3. Trends Cardiovasc Med. 2001. PMID: 11685998 Review.

2

Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical events.

Heinecke JW, Suits AG, Aviram M, Chait A. Heinecke JW, et al. Arterioscler Thromb. 1991 Nov-Dec;11(6):1643-51. doi: 10.1161/01.atv.11.6.1643. Arterioscler Thromb. 1991. PMID: 1657129

3

Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation.

Suits AG, Chait A, Aviram M, Heinecke JW. Suits AG, et al. Among authors: heinecke jw. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2713-7. doi: 10.1073/pnas.86.8.2713. Proc Natl Acad Sci U S A. 1989. PMID: 2704743 Free PMC article.

4

Superoxide initiates oxidation of low density lipoprotein by human monocytes.

Hiramatsu K, Rosen H, Heinecke JW, Wolfbauer G, Chait A. Hiramatsu K, et al. Among authors: heinecke jw. Arteriosclerosis. 1987 Jan-Feb;7(1):55-60. doi: 10.1161/01.atv.7.1.55. Arteriosclerosis. 1987. PMID: 3028347

5

Free radical modification of low-density lipoprotein: mechanisms and biological consequences.

Heinecke JW. Heinecke JW. Free Radic Biol Med. 1987;3(1):65-73. doi: 10.1016/0891-5849(87)90040-2. Free Radic Biol Med. 1987. PMID: 3040538 Review.

6

Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.

Shaish A, Daugherty A, O'Sullivan F, Schonfeld G, Heinecke JW. Shaish A, et al. Among authors: heinecke jw. J Clin Invest. 1995 Oct;96(4):2075-82. doi: 10.1172/JCI118256. J Clin Invest. 1995. PMID: 7560102 Free PMC article.

7

Dissociation between tissue iron concentrations and transferrin saturation among inbred mouse strains.

Leboeuf RC, Tolson D, Heinecke JW. Leboeuf RC, et al. Among authors: heinecke jw. J Lab Clin Med. 1995 Aug;126(2):128-36. J Lab Clin Med. 1995. PMID: 7636385

8

Lipoprotein modification: cellular mechanisms.

Chait A, Heinecke JW. Chait A, et al. Among authors: heinecke jw. Curr Opin Lipidol. 1994 Oct;5(5):365-70. doi: 10.1097/00041433-199410000-00008. Curr Opin Lipidol. 1994. PMID: 7858911 Review.

9

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Daugherty A, et al. Among authors: heinecke jw. J Clin Invest. 1994 Jul;94(1):437-44. doi: 10.1172/JCI117342. J Clin Invest. 1994. PMID: 8040285 Free PMC article.

10

Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.

Kawamura M, Heinecke JW, Chait A. Kawamura M, et al. Among authors: heinecke jw. J Clin Invest. 1994 Aug;94(2):771-8. doi: 10.1172/JCI117396. J Clin Invest. 1994. PMID: 8040332 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results